Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

ÀÌÇϼ± ¾ç¼ºÁ¾¾ç¿¡¼­ Á¦ÇÑÀû ºÎºÐ ÀÌÇϼ± ÀýÁ¦¼úÀÇ À¯¿ë¼º Role of Limited Partial Parotidectomy in the Management of Benign Parotid Tumors

´ëÇѵΰæºÎÁ¾¾çÇÐȸÁö 2011³â 27±Ç 1È£ p.54 ~ 58
Á¤¼ºµµ, ¾È¼¼¿µ, ¹Úº´°Ç, ÀÌ»óÁØ, Á¤ÇÊ»ó,
¼Ò¼Ó »ó¼¼Á¤º¸
Á¤¼ºµµ ( Jung Sung-Do ) 
´Ü±¹´ëÇб³ ÀÇ°ú´ëÇÐ À̺ñÀÎÈÄ°úÇб³½Ç

¾È¼¼¿µ ( An Se-Young ) 
´Ü±¹´ëÇб³ ÀÇ°ú´ëÇÐ À̺ñÀÎÈÄ°úÇб³½Ç
¹Úº´°Ç ( Park Byung-Keon ) 
°Ç¾ç´ëÇб³ ÀÇ°ú´ëÇÐ À̺ñÀÎÈÄ°úÇб³½Ç
ÀÌ»óÁØ ( Lee Sang-joon ) 
´Ü±¹´ëÇб³ ÀÇ°ú´ëÇÐ À̺ñÀÎÈÄ°úÇб³½Ç
Á¤ÇÊ»ó ( Jung Phil-sang ) 
´Ü±¹´ëÇб³ ÀÇ°ú´ëÇÐ À̺ñÀÎÈÄ°úÇб³½Ç

Abstract


Objectives : There are many reports on attempts to minimize complications and recurrences of tumor by several techniques for benign parotid tumor resection. The purpose of our study is to find out meaning of procedure without identifying main trunk of facial nerve compared to conventional parotidectomy.

Material and Methods : We classified 121 patients into two groups. Patients who were underwent superficial parotidectomy or partial superficial parotidectomy were included in idenitification group(IF group), and patients who were treated with conservative partial parotidectomy or extracapsular dissection without identification of main trunk of facial nerve were included in the non-identification group(NF group). We analyzed the location of tumor, operation time, mean drainage duration, complication, recurrence and cosmetic satisfaction in two groups.

Results : NF group has shorter operation time and mean drainage duration than IF group, however there is no significant difference in complication and recurrence between two surgical techniques. The Cosmetic satisfaction was similar between two groups.

Conclusion : Limited parotidectomy without finding main trunk of facial nerve may be reliable option for benign parotid tumors because it has advantages such as less operation time and mean drainage duration without increasing in recurrence or complication rate.

Å°¿öµå

ÀÌÇϼ± ÀýÁ¦¼ú;ÇǸ·¿Ü ÀýÁ¦¼ú;ÀÌÇϼ± Á¾¾ç
parotidectomy;extracapsular dissection;parotid tumors

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

µîÀçÀú³Î Á¤º¸

KAMS